45
Views
1
CrossRef citations to date
0
Altmetric
Review

Liver resections: complications and survival outcome

Pages 269-279 | Published online: 09 Jan 2014

References

  • Gozzetti G, Mazziotti A, Grazi GL. HPB Surgery: an independent specialty or a branch of digestive surgery? HPB Surg.8, 111–113 (1994).
  • Bolondi L. Screening for hepatocellular carcinoma in cirrhosis. J. Hepatol.39(6), 1076–1084 (2003).
  • Ton That Tung. Le cancer primaire du foie au Viet-nam. Chirurgie99, 427–436 (1973).
  • Bolondi L, Sofia S, Siringo S et al. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut48(2), 251–259 (2001).
  • Trevisani F, De Notariis S, Rapaccini G et al. Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience). Am. J. Gastroenterology97(3), 734–744 (2002).
  • Bruix J, Sherman M. Management of hepatocellular carcinoma. Practice Guidelines Committee, American Association for the Study of Liver Diseases. Hepatology42(5), 1208–1236 (2005).
  • Grazi GL. Web relationships between physicians and individuals seeking information on hepatopancreatobiliary diseases. Arch. Surg.141(12), 1176–1182 (2006).
  • Yokoyama Y, Nagino M, Nimura Y. Mechanisms of hepatic regeneration following portal vein embolization and partial hepatectomy: a review. World J. Surg.31(2), 367–374 (2007).
  • Johnson TN, Tucker GT, Tanner MS, Rostami-Hodjegan A. Changes in liver volume from birth to adulthood: a meta-analysis. Liver Transpl.11(12), 1481–1493 (2005).
  • Kubota K, Makuuchi M, Kusaka K et al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology26(5), 1176–1181 (1997).
  • Truant S, Oberlin O, Sergent G et al. Remnant liver volume to body weight ratio ≥ 0.5%: a new cut-off to estimate postoperative risks after extended resection in noncirrhotic liver. J. Am. Coll. Surg.204(1), 22–33 (2007).
  • Pang YY, Strasberg SM. The Brisbane 2000 terminology of liver anatomy and resections. J. Hepatobiliary Pancreat. Surg.2, 333–339 (2000).
  • Lin T, Tsu K, Mien C et al. Study on lobectomy of the liver. J. Formosa Med. Assoc.57, 742–759 (1958).
  • Lin TY. A simplified technique for hepatic resection: the crush method. Ann. Surg.180, 285–290 (1974).
  • Liu CL, Fan ST, Cheung ST, Lo CM, Ng IO, Wong J. Anterior approach versus conventional approach right hepatic resection for large hepatocellular carcinoma: a prospective randomized controlled study. Ann. Surg.244(2), 194–203 (2006).
  • Lesurtel M, Selzner M, Petrowsky H, McCormack L, Clavien PA. How should transection of the liver be performed? A prospective randomized study in 100 consecutive patients: comparing four different transection strategies. Ann. Surg.242, 814–823 (2005).
  • Takayama T, Makuuchi M, Kubota K et al. Randomized comparison of ultrasonic vs clamp transection of the liver. Arch. Surg.136, 922–928 (2001).
  • Lupo L, Gallerani A, Panzera P, Tandoi F, Di Palma G, Memeo V. Randomized clinical trial of radiofrequency-assisted versus clamp-crushing liver resection. Br. J. Surg.94, 287–291 (2007).
  • Gozzetti G, Mazziotti A, Grazi GL et al. Liver resection without blood transfusion. Br. J. Surg.82, 1105–1110 (1995).
  • Pringle JH. Note on the arrest of hepatic hemorrhage due to trauma. Ann. Surg.48, 541–549 (1908).
  • Belghiti J, Noun R, Malafosse R et al. Continuous versus intermittent portal triad clamping for liver resection: a controlled study. Ann. Surg.229(3), 369–375 (1999).
  • Clavien PA, Petrowsky H, DeOliveira ML, Graf R. Strategies for safer liver surgery and partial liver transplantation. N. Engl. J. Med.356(15), 1545–1559 (2007).
  • Esaki M, Sano T, Shimada K et al. Randomized clinical trial of hepatectomy using intermittent pedicle occlusion with ischaemic intervals of 15 versus 30 minutes. Br. J. Surg.93(8), 944–951 (2006).
  • Makuuchi M, Mori T, Gunvén P, Yamazaki S, Hasegawa H. Safety of hemihepatic vascular occlusion during resection of the liver. Surg. Gynecol. Obstet.164(2), 155–158 (1987).
  • Figueras J, Llado L, Ruiz D et al. Complete versus selective portal triad clamping for minor liver resections: a prospective randomized trial. Ann. Surg.241(4), 582–590 (2005).
  • Grazi GL, Mazziotti A, Jovine E et al. Total vascular exclusion of the liver during hepatic surgery: selective use, extensive use or abuse. Arch. Surg.132, 1104–1110 (1997).
  • Capussotti L, Muratore A, Ferrero A, Massucco P, Ribero D, Polastri R. Randomized clinical trial of liver resection with and without hepatic pedicle clamping. Br. J. Surg.93(6), 685–689 (2006).
  • Huguet C, Nordlinger B, Galopin JJ, Bloch P, Gallot D. Normothermic hepatic vascular exclusion for extensive hepatectomy. Surg. Gynecol. Obstet.147(5), 689–693 (1978).
  • Delva E, Camus Y, Nordlinger B et al. Vascular occlusions for liver resections: operative management and tolerance to hepatic ischemia. Ann. Surg.209, 211–218 (1989).
  • Cherqui D, Malassagne B, Colau PH et al. Hepatic vascular exclusion with preservation of the caval flow for liver resections. Ann. Surg.230(1), 24–30 (1999).
  • Melendez JA, Arslan V, Fischer ME et al. Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction. J. Am. Coll. Surg.187(6), 620–625 (1998).
  • Figueras J, Llado L, Miro M et al. Application of fibrin glue sealant after hepatectomy does not seem justified. Results of a randomized study in 300 patients. Ann. Surg. (2007) (In Press).
  • Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann. Surg.240(2), 205–213 (2004).
  • Imamura H, Seyama Y, Kokudo N et al. One thousand fifty-six hepatectomies without mortality in 8 years. Arch. Surg.138(11), 1198–1206 (2003).
  • Balzan S, Belghiti J, Farges O et al. The “50–50 criteria” on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann. Surg.242(6), 824–828 (2005).
  • Mullen JT, Ribero D, Reddy SK et al. Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. J. Am. Coll. Surg.204(5), 854–862 (2007).
  • Vauthey JN, Chaoui A, Do KA et al. Standardized measurement of the future liver remnant before extended liver resection: methodology and clinical associations. Surgery127, 512–519 (2000).
  • Kiuchi T, Kasahara M, Uryuhara K et al. Impact of graft size mismatching on graft prognosis in liver transplantation from living donors. Transplantation67(2), 321–327 (1999).
  • Fan ST, Lo CM, Liu CL, Yong BH, Chan JK, Ng IO. Safety of donors in live donor liver transplantation using right lobe grafts. Arch. Surg.135(3), 336–340 (2000).
  • Makuuchi M, Thai BL, Takayasu K et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery107(5), 521–527 (1990).
  • Imamura H, Shimada R, Kubota M et al. Preoperative portal vein embolization: an audit of 84 patients. Hepatology29(4), 1099–1105 (1999).
  • Azoulay D, Castaing D, Krissat J et al. Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann. Surg.232(5), 665–672 (2000).
  • Adam R, Laurent A, Azoulay D, Castaing D, Bismuth H. Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann. Surg.232(6), 777–785 (2000).
  • Ercolani G, Principe A, Ravaioli M, Cescon M, Grazi GL. Long-term survival after two-stage hepatectomy for colorectal metastases: a case report. Hepatogastroenterology51(56), 592–594 (2004).
  • Child CG II, Turcotte JG. Surgery and portal hypertension. In: The Liver and Portal Hypertension. Child CG III (Ed.). Saunders, PA, USA, 50–58 (1964).
  • Pugh RN, Murray-Lyon IM, Dawson JL et al. Transection of the oesophagus for bleeding oesophageal varices. Br. J. Surg.60, 646–649 (1973).
  • Ercolani G, Grazi GL, Callivà R et al. The lidocaine (MEGX) test as an index of hepatic function: its clinical usefulness in liver surgery. Surgery127(4), 464–471 (2000).
  • Mullin EJ, Metcalfe MS, Maddern GJ. How much liver resection is too much? Am. J. Surg.190, 87–97 (2005).
  • Cucchetti A, Ercolani G, Vivarelli M et al. Impact of Model for End-Stage Liver Disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. Liver Transpl.12, 966–971 (2006).
  • Bruix J, Castells A, Bosch J et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology111(4), 1018–1022 (1996).
  • Ebata T, Nagino M, Kamiya J, Uesaka K, Nagasaka T, Nimura Y. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases. Ann. Surg.238(5), 720–727 (2003).
  • Nagino M, Kamiya J, Arai T, Nishio H, Ebata T, Nimura Y. One hundred consecutive hepatobiliary resections for biliary hilar malignancy: preoperative blood donation, blood loss, transfusion, and outcome. Surgery137(2), 148–155 (2005).
  • Tsao JI, Nimura Y, Kamiya J et al. Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience. Ann. Surg.232(2), 166–174 (2000).
  • Grazi GL, Ercolani G, Pierangeli F et al. Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value. Ann. Surg.234, 71–78 (2001).
  • Cucchetti A, Ercolani G, Cescon M et al. Recovery from liver failure after hepatectomy for hepatocellular carcinoma in cirrhosis: meaning of the model for end-stage liver disease. J. Am. Coll. Surg.203(5), 670–676 (2006).
  • Hayashibe A, Sakamoto K, Shinbo M, Makimoto S, Nakamoto T. New method for prevention of bile leakage after hepatic resection. J. Surg. Oncol.94(1), 57–60 (2006).
  • Yamashita Y, Hamatsu T, Rikimaru T et al. Bile leakage after hepatic resection. Ann. Surg.233(1), 45–50 (2001).
  • Ijichi M, Takayama T, Toyoda H, Sano K, Kubota K, Makuuchi M. Randomized trial of the usefulness of a bile leakage test during hepatic resection. Arch. Surg.135(12), 1395–1400 (2000).
  • Tanaka S, Hirohashi K, Tanaka H et al. Incidence and management of bile leakage after hepatic resection for malignant hepatic tumors. J. Am. Coll. Surg.195(4), 484–489 (2002).
  • Grazi GL, Cescon M, Ravaioli M et al. Liver resection for hepatocellular carcinoma in cirrhotics and noncirrhotics. Evaluation of clinicopathologic features and comparison of risk factors for long-term survival and tumour recurrence in a single centre. Aliment. Pharmacol. Ther.17(Suppl. 2), 119–129 (2003).
  • Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ, Rees M. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br. J. Cancer94, 982–999 (2006).
  • Ebara M, Ohto M, Shinagawa T et al. Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. A study in 22 patients. Gastroenterology90(2), 289–298 (1986).
  • Llovet JM, Bustamante J, Castells A et al. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology29(1), 62–67 (1999).
  • Llovet JM, Schwartz M, MazzaferroV. Resection and liver transplantation for hepatocellular carcinoma. Semin. Liver Dis.25(2), 181–200 (2005).
  • Ercolani G, Grazi GL, Ravaioli M et al. Liver resection for hepatocellular carcinoma on cirrhosis: a univariate and multivariate analysis of risk factors for intrahepatic recurrence. Ann. Surg.237(4), 536–543 (2003).
  • Belghiti J, Panis Y, Farges O, Benhamou JP, Fekete F. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann. Surg.214(2), 114–117 (1991).
  • Chen YJ, Yeh SH, Chen JT et al. Chromosomal changes and clonality relationship between primary and recurrent hepatocellular carcinoma. Gastroenterology119, 431–440 (2000).
  • Ng IO, Guan XY, Poon RT, Fan ST, Lee JM. Determination of the molecular relationship between multiple tumor nodules in hepatocellular carcinoma differentiates multicentric origin from intrahepatic metastasis. J. Pathol.199(3), 345–353 (2003).
  • Stangl R, Altendorf-Hofmann A, Charnley RM, Scheele J. Factors influencing the natural history of colorectal liver metastases. Lancet343, 1405–1410 (1994).
  • Ercolani G, Grazi GL, Ravaioli M et al. Liver resection for multiple colorectal metastases: parenchymal involvement and total tumor volume, not number or location, significantly affect long term survival. Arch. Surg.137(10), 1187–1192 (2002).
  • Garden OJ, Rees M, Poston GJ et al. Guidelines for resection of colorectal cancer liver metastases. Gut55, 1–8 (2006).
  • Biasco G, Derenzini E, Grazi GL et al. Treatment of hepatic metastases from colorectal cancer: many doubts, some certainties. Cancer Treat. Rev.32(3), 214–228 (2006).
  • Sugawara G, Isogai M, Kaneoka Y, Suzuki M, Yamaguchi A. Repeat hepatectomy for recurrent colorectal metastases. Surg. Today35, 282–289 (2005).
  • Yan TD, Lian KQ, Chang D, Morris DL. Management of intrahepatic recurrence after curative treatment of colorectal liver metastases. Br. J. Surg.93, 854–859 (2006).
  • Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier AM. Epidemiology and management of liver metastases from colorectal cancer. Ann. Surg.244(2), 254–259 (2006).
  • Grazi GL, Cescon M, Pierangeli F, Ercolani M, Gardini A, Cavallari A. Highly aggressive policy of hepatic resections for neuroendocrine liver metastases. Hepatogastroenterology47(32), 481–486 (2000).
  • Ercolani G, Grazi GL, Ravaioli M et al. The role of liver resections for noncolorectal, nonneuroendocrine metastases: experience with 142 observed cases. Ann. Surg. Oncol.12(6), 459–466 (2005).
  • Weitz J, Blumgart LH, Fong Y et al. Partial hepatectomy for metastases from noncolorectal, nonneuroendocrine carcinoma. Ann. Surg.241(2), 269–276 (2005).
  • Adam R, Chiche L, Aloia T et al. Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model. Ann. Surg.244(4), 524–535 (2006).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.